In vivo, 5-FU treatment elevated the expression of CCL20 in colorectal cancer cells (CRC) by activating FOXO1/CEBPB/NF-κB signaling, which promoted the recruitment of Tregs within TME. Here, NFKB1 is linked to colorectal carcinoma.